Target intelligence / Profile preview

HOXC cluster antisense RNA 2 (HOXC-AS2)

Target
HOXC-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other (regulatory non-coding RNA)
01

Overview

HOXC cluster antisense RNA 2 (HOXC-AS2) is a long non-coding RNA transcribed antisense from the HOXC genomic locus. Unlike protein-coding genes, HOXC-AS2 regulates gene expression, cell proliferation, apoptosis, and the cell cycle, especially through interactions with adjacent HOXC cluster genes such as HOXC13[4][1]. It is increasingly recognized as a disease-associated RNA, particularly in non-small cell lung cancer, where it modulates malignant cell behaviors. HOXC-AS2 functions largely through epigenetic mechanisms and antisense interactions that regulate chromatin state and transcriptional output, contributing to both normal development and disease pathology[1][3][4]. No drugs directly targeting HOXC-AS2 are identified yet, but its disease-related regulatory activity positions it as a candidate biomarker and prospective therapeutic target.

Other names
HOXC cluster antisense RNA 2 (non-protein coding)HOXC-AS2
02

Mechanism of action

Epigenetic regulation via binding to chromatin modifiers (by analogy to related HOX-antisense RNAs like HOTAIR; likely recruitment of Polycomb group proteins, though direct data for HOXC-AS2 is limited)[7]; Regulatory antisense interactions with HOXC13 and other HOXC cluster genes[4]; Modulation of gene expression via sense-antisense transcript pairing[1][5]

03

Biological functions

Regulation of cell proliferation[4]Regulation of apoptosis[4][3]Regulation of cell cycle[4][3]Regulation of cell migration (especially in cancers)[4]Transcriptional regulation (through antisense pairing and epigenetic modifications)[1][3]
04

Disease associations

Cancer (non-small cell lung cancer, general pan-cancer)[4][6]Cardiovascular disease (potential role in atherosclerosis through vascular cell regulation)[3]Other disease relevance—may be involved broadly in developmental disorders due to its role in HOXC gene regulation[1]
05

Safety considerations

The major therapeutic challenge is the specificity of RNA-targeted therapeutics and the risk of off-target effects, given the dense genomic regulation within HOX clusters[1][5]Potential for dysregulation leading to developmental or oncogenic side effects due to broad role in cell cycle and apoptosis
06

Interacting drugs

None directly documented as of now; HOXC-AS2 is a novel molecule of interest as a potential target or biomarker, thus no specific drugs are known to directly bind or modulate it at present.
07

Biomarkers

HOXC-AS2 expression level may serve as a prognostic biomarker in non-small cell lung cancer and other malignancies[4][6]HOXC-AS2 levels may be used as a biomarker for regulatory activity in vascular diseases (parallel to HOXA-AS2 in atherosclerosis)[3]

Beyond the preview

Go deeper on HOXC cluster antisense RNA 2 (HOXC-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOXC cluster antisense RNA 2 (HOXC-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call